查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1912423

醫藥市場PET包裝：按包裝類型、藥品類型、填充和封裝工藝、永續性解決方案以及最終用戶分類－2026年至2032年全球市場預測

PET Packaging In the Pharmaceutical Market by Packaging Type, Drug Type, Fill-Finish, Sustainability Solution, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫藥 PET 包裝市場規模將達到 65.6 億美元，到 2026 年將達到 71 億美元，到 2032 年將達到 123.2 億美元，複合年成長率為 9.40%。

關鍵市場統計數據
基準年 2025 65.6億美元
預計年份：2026年 71億美元
預測年份 2032 123.2億美元
複合年成長率 (%) 9.40%

針對PET藥品包裝的策略方法，為供應鏈領導者闡明監管重點、材料性能權衡以及營運影響。

製藥業面臨嚴格的監管、複雜的供應鏈和不斷變化的患者期​​望，而包裝是支撐這一切的關鍵組成部分。聚對苯二甲酸乙二醇酯（通常稱為PET）已成為一種用途廣泛的材料，它能夠支援日益豐富的藥物劑型，同時兼顧阻隔功能、可製造性和成本效益。本分析清楚地闡述了包裝決策的重要性，它不僅關乎內容物的盛裝，還會影響低溫運輸物流、劑量準確性、患者依從性以及在監管檢查中證明合規性的能力。

監管重點、材料創新和永續性需求如何融合，重新定義PET包裝的設計、製造和供應策略

由於三大因素的共同作用，PET藥品包裝市場正經歷變革性的轉變：日益嚴格的監管、技術的創新以及永續性的迫切需求。在監管方面，監管機構日益重視可萃取物和可浸出物測試、序列化防偽以及包裝相容性認證，迫使製造商採用更嚴格的材料評估和文件記錄方法。同時，阻隔塗層、共聚物配方和積層製造技術的進步，使得PET能夠應用於以往由玻璃和HDPE主導的領域，從而拓展了藥品包裝容器的組合範圍。

不斷變化的關稅政策如何影響全球供應鏈中的藥品包裝採購、供應商選擇策略和彈性規劃

關稅環境和貿易政策的調整將對籌資策略、供應商選擇和區域製造地地點產生重大影響。在美國，近期政策週期中引入的關稅變化正促使製藥公司和包裝供應商重新思考其籌資策略，探索近岸外包方案，並增強供應鏈的韌性。這些措施促使他們重新評估總到岸成本 (TLC) 的計算方法，不再僅僅關注單位成本，而是將前置作業時間、庫存緩衝以及與合格替代供應商相關的營運成本也納入考慮。

一個全面的細分框架，用於識別材料、規格、填充/表面處理和永續性之間的權衡取捨，以指導包裝開發和採購決策。

深入的細分分析突顯了包裝類型、藥物劑型、最終用戶、填充/包裝方法以及永續性偏好如何導致技術要求和商業性優先事項的差異。基於包裝類型，此細分市場分為安瓿/管瓶、泡殼包裝、瓶裝和注射器/藥筒。瓶裝進一步細分為多劑量和單劑量規格，注射器/藥筒則分為藥筒和預填充式注射器。這種分類方案揭示了對阻隔性能、劑量精度和密封系統的需求如何驅動材料選擇和二級包裝設計。

區域監管差異、製造地集中度和永續性政策如何為全球PET包裝市場帶來不同的策略要務

區域趨勢對原料供應、監管預期和供應鏈結構有顯著影響。在美洲，複雜生物製藥的高普及率以及成熟的法規環境（強調序列化和全面的包裝驗證）正在塑造需求模式，促使企業投資於完善的品質系統和本地供應商資格認證。北美企業通常優先考慮產品上市速度和透明的供應鏈，這些優先事項體現在其採購選擇和對自動化灌裝包裝能力的投資。

競爭定位洞察：揭示技術整合、監管嚴格性和永續性夥伴關係如何定義市場領導地位和供應商差異化

深入觀察成熟企業和新興企業企業，可以發現它們在技術投資、永續性措施和客戶參與方面採取了不同的策略。主要企業正專注於建立整合精密成型、先進阻隔解決方案和相容性測試服務的平台，以加快客戶認證速度。一些企業也與回收商和材料開發商建立策略合作夥伴關係，以確保穩定的再生PET原料供應，並共同開發符合可萃取性和可浸出性標準的醫藥級再生材料。

包裝領導企業正在採取切實可行的策略步驟，以提高供應商的韌性，加速永續材料的採用，並最佳化其產品組合中的填充和包裝製造流程。

產業領導者應制定一項三管齊下的行動計劃，將技術能力、供應鏈韌性和永續性路徑相結合。首先，應優先進行跨職能的資質認證項目，透過雙重採購和模組化驗證通訊協定降低供應商風險，縮短供應商過渡時間，同時確保產品品質。投資於驗證工具包和共用試驗框架，可以加快新供應商的引入速度，並減少因更換供應商而造成的營運中斷。

採用嚴謹的混合方法研究，整合專家訪談、技術文獻和供應鏈實證數據，以得出可操作且檢驗的包裝洞察。

本分析所依據的研究採用了多種方法，以平衡的證據為基礎得出結論。研究人員透過訪談製藥企業和合約包裝商的包裝工程師、法規事務人員、採購經理和研發經理，收集了第一手數據，以深入了解材料性能、合格要求和操作限制。隨後，研究人員將這些定性研究結果與聚合物化學的技術文獻、容器相容性法規指南以及已發布的產品規格進行交叉比對，以檢驗材料性能和相容性聲明的準確性。

對技術進步、監管要求和永續性措施如何共同影響製藥業領導者的PET包裝策略進行綜合分析

PET包裝在現代醫藥物流和產品設計中扮演著至關重要的角色，其優異的性能、易加工性和可回收性使其成為多種藥物劑型的理想選擇。不斷變化的監管要求、材料科學的創新以及日益成長的永續性期望，正迫使製造商和供應商重新思考包裝架構和供應商關係。這項轉變需要嚴謹的檢驗，以確保病患安全和產品穩定性，同時也為最佳化灌裝和表面處理工程、降低系統總成本以及滿足相關人員對環境績效的期望創造了機會。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：按包裝類型分類的藥品市場

  • 安瓿瓶與管瓶
  • 泡殼包裝
  • 瓶子
    • 多劑量瓶
    • 單劑量瓶
  • 注射器和藥筒
    • 墨水匣
    • 預填充式注射器

第9章：按藥物類型分類的藥品市場

  • 注射
  • 液體
  • 營養補充品
  • 粉末
  • 片劑和膠囊
    • 膠囊
    • 藥片

第10章 以填充和包裝流程分類的藥品市場

  • 自動的
  • 手動的

第11章：永續解決方案下的醫藥市場

  • 回收PET
    • 化學回收
    • 機械再生
  • 處女寵物
    • 擠出吹塑成型
    • 射出成型

第12章：依最終用戶分類的藥品市場

  • 居家醫療
  • 醫院和診所
  • 零售藥房

第13章：各地區的醫藥市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：依組別分類的藥品市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：各國藥品市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章美國醫藥市場

第17章：中國醫藥市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ALPLA Werke Alwin Lehner GmbH & Co KG
  • Amcor plc
  • AptarGroup, Inc.
  • Berry Global, Inc.
  • Catalent, Inc.
  • CCL Industries Inc.
  • Constantia Flexibles GmbH
  • Drug Plastics & Glass Co., Inc
  • Gerresheimer AG
  • Graham Packaging Company
  • Klockner Pentaplast Group GmbH & Co. KG
  • Nipro Corporation
  • Plastipak Packaging, Inc.
  • Silgan Holdings Inc.
Product Code: MRR-AE420CB13993

The PET Packaging In the Pharmaceutical Market was valued at USD 6.56 billion in 2025 and is projected to grow to USD 7.10 billion in 2026, with a CAGR of 9.40%, reaching USD 12.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.56 billion
Estimated Year [2026] USD 7.10 billion
Forecast Year [2032] USD 12.32 billion
CAGR (%) 9.40%

A strategic orientation to PET pharmaceutical packaging that frames regulatory priorities, material performance trade-offs, and operational implications for supply chain leaders

The pharmaceutical industry sits at the intersection of stringent regulation, complex supply chains, and evolving patient expectations, and packaging is a critical enabler of all three. Polyethylene terephthalate, commonly known as PET, has emerged as a versatile material that balances barrier functionality, manufacturability, and cost efficiency while supporting an expanding palette of drug formats. This analysis opens with a clear-eyed overview of why packaging decisions matter beyond containment: they affect cold-chain logistics, dosing integrity, patient adherence, and the ability to demonstrate compliance during regulatory inspections.

Moreover, contemporary pressures such as the drive for sustainable materials, the rise of biologics and prefilled delivery systems, and the need to streamline fill-finish operations are reshaping packaging strategies across the pharmaceutical value chain. The introduction establishes how PET offerings are being engineered to meet sterility requirements, compatibility demands for a range of drug chemistries, and the practicalities of automated assembly lines. It also frames the competing priorities that supply chain leaders and packaging engineers must reconcile, including shelf life versus recyclability and performance versus cost.

The introduction thus sets the stage for an actionable executive summary, clarifying the scope of subsequent sections and establishing the analytical lens through which technology adoption, regional dynamics, and company-level strategies will be evaluated.

How regulatory focus, material innovation, and sustainability imperatives are converging to redefine PET packaging design, manufacturing, and supply strategies

The landscape for PET packaging in pharmaceuticals is undergoing transformative shifts driven by three converging forces: regulatory tightening, technological innovation, and sustainability imperatives. On the regulatory front, agencies are placing greater emphasis on extractables and leachables testing, serialization for anti-counterfeiting, and evidence of packaging compatibility, prompting manufacturers to adopt more rigorous material evaluation and documentation practices. In parallel, technological progress in barrier coatings, co-polymer formulations, and additive manufacturing is enabling PET to address applications previously dominated by glass or HDPE, widening the scope of possible drug-container pairings.

Sustainability has moved from a corporate social responsibility talking point to an operational imperative. Recycled PET pathways, including both mechanical and chemical recycling streams, are being piloted to reduce lifecycle carbon intensity while maintaining pharmaceutical-grade integrity. At the same time, advances in prefilled syringe technologies and cartridge forms are reshaping delivery formats, requiring design-led approaches to PET molding and sealing. These innovations are further amplified by automation trends in fill-finish operations, where end-to-end lines are being reconfigured to minimize human contact and increase throughput without compromising sterility.

Taken together, these shifts are redefining procurement criteria and design priorities. Manufacturers and contract packagers are increasingly selecting packaging solutions through a multidimensional lens that accounts for regulatory evidence, lifecycle impacts, manufacturability, and patient use scenarios.

How evolving tariff policies are reshaping pharmaceutical packaging procurement, supplier qualification strategies, and resilience planning across global supply chains

Tariff environments and trade policy adjustments can materially influence procurement strategies, supplier selection, and regional manufacturing footprints. In the United States, tariff changes prompted in recent policy cycles have incentivized pharmaceutical companies and packaging suppliers to reconsider sourcing strategies, explore nearshoring options, and enhance supply chain resiliency. These dynamics encourage a reassessment of the total landed cost equation that extends beyond unit price to include lead times, inventory buffers, and the operational costs associated with quality qualification of alternate suppliers.

Consequently, procurement teams are increasingly prioritizing supplier diversification and dual sourcing to mitigate the risk of abrupt policy shifts. This has led to strategic investments in supplier qualification programs, longer validation pipelines, and contingency planning for capacity allocation. Where tariffs have increased the friction for imported components, some firms have accelerated localization of critical tooling and mold production, recognizing that upfront capital investment can offset recurrent tariff exposure and reduce vulnerability to trade disruptions.

At the same time, trade dynamics are influencing decisions about sustainable material sourcing. The economics of recycled PET streams can shift with tariff-induced changes to cross-border material flows, affecting the feasibility of certain circularity models. Organizations are therefore adopting scenario planning to understand how tariff policy may interact with sustainability commitments, supply continuity, and long-term supplier partnerships.

A comprehensive segmentation framework that clarifies material, format, fill-finish, and sustainability trade-offs to guide packaging development and procurement decisions

Insightful segmentation analysis highlights how technical requirements and commercial priorities vary by packaging type, drug form, end user, fill-finish method, and sustainability choice. Based on Packaging Type, the landscape is evaluated across ampoules and vials, blister packs, bottles, and syringes and cartridges, with bottles further differentiated into multi-dose and single-dose formats, and syringes and cartridges further delineated into cartridges and pre-filled syringes; this taxonomy helps reveal how barrier needs, dosing accuracy, and closure systems drive material selection and secondary packaging design.

Based on Drug Type, distinctions among injectables, liquids, nutraceuticals, powders, and tablets and capsules inform compatibility testing priorities and contamination risk profiles, while tablets and capsules are examined through the lens of capsule versus tablet formats to identify packaging robustness and labeling requirements. Based on End User, the segmentation across home healthcare, hospitals and clinics, and retail pharmacies sheds light on differing usability and patient safety considerations, such as child-resistant features for retail pharmacies versus high-throughput dispensability for hospitals and clinics.

Based on Fill-Finish, the contrast between automatic and manual processes is instrumental in evaluating container geometry, neck finish tolerances, and sealing technologies that facilitate automated capping and inspection. Based on Sustainability Solution, the choices between recycled PET and virgin PET, with recycled PET further examined through chemical and mechanical recycling paths and virgin PET analyzed by extrusion blow molding versus injection molding methods, reveal trade-offs between material performance, regulatory compliance for pharmaceutical use, and circularity ambitions.

Together, these segmentation lenses enable targeted product development and procurement strategies that align technical specifications with commercial and regulatory priorities.

How cross-regional regulatory divergence, manufacturing density, and sustainability policy create distinct strategic imperatives for PET packaging across global markets

Regional dynamics exert a strong influence on material availability, regulatory expectations, and supply chain architecture. In the Americas, demand patterns are shaped by a high prevalence of complex biologics and a mature regulatory environment that emphasizes serialization and extensive packaging validation, prompting investments in robust quality systems and local supplier qualification. North American players frequently prioritize rapid time to market and transparent supply chains, and these priorities are reflected in sourcing choices and investments in automated fill-finish capacity.

In Europe, the Middle East and Africa, the regulatory landscape is heterogeneous, with leading European jurisdictions advancing ambitious circularity targets while regions within the Middle East and Africa present divergent infrastructure maturity and logistical challenges. These differences drive a mix of centralized production hubs and regional packaging strategies that balance compliance with cost-effective distribution models. Adoption of recycled PET streams in certain European markets is accelerating, influenced by both policy measures and consumer expectations.

In the Asia-Pacific region, dynamics are shaped by large-scale manufacturing ecosystems, a growing domestic pharmaceutical market, and rapid advancement in injection and prefilled device adoption. Supply chain efficiencies and competitive supplier bases have made the region a focal point for tooling and high-volume production, while regulatory harmonization efforts continue to evolve to address material compatibility and serialization across national boundaries. Collectively, regional insights inform decisions about where to locate critical manufacturing steps, how to structure supplier networks, and how to reconcile sustainability commitments with operational realities.

Competitive positioning insights showing how technology integration, regulatory rigor, and sustainability partnerships are defining market leadership and supplier differentiation

A careful examination of incumbent and emerging companies reveals differentiated approaches to technology investment, sustainability positioning, and customer engagement. Leading suppliers are converging on platforms that integrate high-precision molding, advanced barrier solutions, and compatibility testing services to reduce qualification time for customers. Some firms are also forging strategic alliances with recyclers and material innovators to secure feedstock for recycled PET streams and to co-develop pharmaceutical-grade recycled materials that meet extractables and leachables standards.

Contract packaging organizations are investing heavily in automated fill-finish lines and in digital quality management systems that enable traceability and reduce time-to-release. This operational focus is complemented by collaborative R&D programs with pharmaceutical manufacturers to tailor container-closure systems for specific drug chemistries, particularly for biologics and sensitive injectables. New entrants are differentiating through niche offerings such as specialized prefilled device formats or single-use systems engineered for ease of patient self-administration.

Across the competitive landscape, the combination of manufacturing excellence, demonstrable regulatory evidence, and sustainability credentials is becoming the basis for winning long-term partnerships. Companies that can provide integrated solutions encompassing material sourcing, validation support, and logistics services are positioned to capture greater strategic value in customer relationships.

Practical strategic moves for packaging leaders to improve supplier resilience, accelerate sustainable material adoption, and optimize fill-finish manufacturability across portfolios

Industry leaders should pursue a three-pronged action agenda that aligns technical capability, supply chain resilience, and sustainability pathways. First, prioritize cross-functional qualification programs that reduce supplier risk through dual sourcing and modular validation protocols, thereby shortening the time required to transition between suppliers while preserving product quality. Investing in validation toolkits and shared trial frameworks enables faster onboarding and decreases the operational disruption of supplier changes.

Second, accelerate adoption of design-for-manufacturability principles that reconcile barrier performance with recyclability objectives. This includes adopting neck finishes and closure interfaces that are compatible with automated fill-finish lines, and working with material scientists to specify PET formulations or coatings that meet extractables standards while facilitating circularity through mechanical or chemical recycling routes. Collaborative pilot projects with recyclers and converters can yield scalable proofs of concept that inform procurement standards.

Third, embed trade policy and regional risk assessment into strategic sourcing decisions by mapping supplier exposure to tariff shifts and logistical bottlenecks. Scenario planning and contractual clauses that allocate risk in defined ways can protect operations, while investments in regional tooling and localized production can serve as effective hedges. Executing on these recommendations will require cross-disciplinary governance, measurable KPIs, and a clear roadmap for iterative improvement.

A rigorous mixed-methods research approach integrating expert interviews, technical literature, and supply chain evidence to produce actionable and verifiable packaging insights

The research underpinning this analysis combined a multi-method approach to ensure balanced, evidence-based conclusions. Primary data were gathered through interviews with packaging engineers, regulatory affairs specialists, procurement leaders, and R&D heads across pharmaceutical manufacturers and contract packagers, providing firsthand perspectives on material performance, qualification requirements, and operational constraints. These qualitative inputs were triangulated with technical literature on polymer chemistry, regulatory guidances on container compatibility, and publicly available product specifications to validate material performance claims and compatibility assertions.

Secondary analysis included a systematic review of patent activity, industry announcements, and reported capital investments in fill-finish automation to identify technology trajectories and investment priorities. The methodology emphasized contextualization rather than projection, focusing on observed changes in supplier behavior, validation practices, and regional sourcing strategies. Throughout the study, attention was paid to ensuring that sustainability claims were assessed against verifiable recycling pathways and documented testing regimes rather than marketing narratives.

Data interpretation prioritized actionable insight: findings were organized to support procurement decisions, product development roadmaps, and regulatory planning. Limitations of the research are acknowledged in areas where proprietary testing data or confidential supplier agreements limited visibility, and recommendations include targeted steps to close these evidence gaps through collaborative trials and supplier data sharing.

A consolidated synthesis of how technological progress, regulatory expectations, and sustainability commitments are jointly shaping PET packaging strategies for pharma leaders

PET packaging occupies a pivotal role in modern pharmaceutical logistics and product design, offering a combination of performance, manufacturability, and potential circularity that makes it an attractive alternative across many drug forms. The interplay of evolving regulatory requirements, innovation in material science, and mounting sustainability expectations is driving manufacturers and suppliers to rethink packaging architectures and supplier relationships. While the transition requires careful validation to ensure patient safety and product stability, it also creates opportunities to optimize fill-finish operations, reduce total system cost, and meet stakeholder expectations around environmental performance.

The cumulative picture is one of pragmatic transformation: incremental technical advances and operational investments are enabling broader adoption of PET across formats while preserving the evidentiary rigor required by regulators. For strategic leaders, the imperative is to align packaging choice with broader business objectives-balancing speed to market, patient-centric design, and long-term sustainability commitments. The insights presented here are intended to inform those decisions and to provide a foundation for targeted pilots, supplier collaborations, and investment choices that can yield measurable business and environmental outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. PET Packaging In the Pharmaceutical Market, by Packaging Type

  • 8.1. Ampoules & Vials
  • 8.2. Blister Packs
  • 8.3. Bottles
    • 8.3.1. Multi-Dose Bottles
    • 8.3.2. Single-Dose Bottles
  • 8.4. Syringes & Cartridges
    • 8.4.1. Cartridges
    • 8.4.2. Pre-Filled Syringes

9. PET Packaging In the Pharmaceutical Market, by Drug Type

  • 9.1. Injectables
  • 9.2. Liquids
  • 9.3. Nutraceuticals
  • 9.4. Powders
  • 9.5. Tablets & Capsules
    • 9.5.1. Capsules
    • 9.5.2. Tablets

10. PET Packaging In the Pharmaceutical Market, by Fill-Finish

  • 10.1. Automatic
  • 10.2. Manual

11. PET Packaging In the Pharmaceutical Market, by Sustainability Solution

  • 11.1. Recycled PET
    • 11.1.1. Chemical Recycled
    • 11.1.2. Mechanical Recycled
  • 11.2. Virgin PET
    • 11.2.1. Extrusion Blow Mould
    • 11.2.2. Injection Mould

12. PET Packaging In the Pharmaceutical Market, by End User

  • 12.1. Home Healthcare
  • 12.2. Hospitals & Clinics
  • 12.3. Retail Pharmacies

13. PET Packaging In the Pharmaceutical Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. PET Packaging In the Pharmaceutical Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. PET Packaging In the Pharmaceutical Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States PET Packaging In the Pharmaceutical Market

17. China PET Packaging In the Pharmaceutical Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ALPLA Werke Alwin Lehner GmbH & Co KG
  • 18.6. Amcor plc
  • 18.7. AptarGroup, Inc.
  • 18.8. Berry Global, Inc.
  • 18.9. Catalent, Inc.
  • 18.10. CCL Industries Inc.
  • 18.11. Constantia Flexibles GmbH
  • 18.12. Drug Plastics & Glass Co., Inc
  • 18.13. Gerresheimer AG
  • 18.14. Graham Packaging Company
  • 18.15. Klockner Pentaplast Group GmbH & Co. KG
  • 18.16. Nipro Corporation
  • 18.17. Plastipak Packaging, Inc.
  • 18.18. Silgan Holdings Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY AMPOULES & VIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY AMPOULES & VIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY AMPOULES & VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MULTI-DOSE BOTTLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MULTI-DOSE BOTTLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MULTI-DOSE BOTTLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SINGLE-DOSE BOTTLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SINGLE-DOSE BOTTLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SINGLE-DOSE BOTTLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CARTRIDGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CARTRIDGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CARTRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PRE-FILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PRE-FILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PRE-FILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY INJECTABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY INJECTABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY LIQUIDS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY LIQUIDS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY NUTRACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY NUTRACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY POWDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY POWDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY AUTOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY AUTOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY AUTOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CHEMICAL RECYCLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CHEMICAL RECYCLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY CHEMICAL RECYCLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MECHANICAL RECYCLED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MECHANICAL RECYCLED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY MECHANICAL RECYCLED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY EXTRUSION BLOW MOULD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY EXTRUSION BLOW MOULD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY EXTRUSION BLOW MOULD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY INJECTION MOULD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY INJECTION MOULD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY INJECTION MOULD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 194. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 195. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 197. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 198. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 199. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 200. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 201. GCC PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 227. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 228. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 230. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 231. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 232. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 233. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 234. G7 PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 236. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 238. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 239. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 241. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 242. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 243. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 244. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 245. NATO PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY BOTTLES, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SYRINGES & CARTRIDGES, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY DRUG TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY TABLETS & CAPSULES, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY FILL-FINISH, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY SUSTAINABILITY SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY RECYCLED PET, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY VIRGIN PET, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA PET PACKAGING IN THE PHARMACEUTICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)